InvestorsHub Logo
Followers 285
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: doogdilinger post# 3127

Monday, 11/16/2015 11:46:29 AM

Monday, November 16, 2015 11:46:29 AM

Post# of 6443
Nice set of VGLS questions Doog! I'd like to know which of their 2 lines they see as marketable first?

Nice to see IR is on top of their game and open to investor questions. Answered them straightforwardly and in a timely fashion. I like the possibility of a collaboration/licensing deal they mention:

Please provide a brief update on the status and expected focus of the co’s TPT & MDT pursuits. For example…which of the 2 is the main focus and closest to the next sequence of material developments unfolding? How will the ongoing clinical trials costs on each be paid for?

Both will be pursued equally but different sources of potential funding. MDT is most likely a collaboration situation, since it works with chemotherapy and off-course grant money. TPT technology will most likely be equity and grant funding.


Anything in particular stand out for you Doog? Again, I like the company is open to answering straight forward questions from its investor base.

Thanks for doing this Doog!

Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.